International consensus on use of focused ultrasound for painful bone metastases: Current status and future directions

References

• Tempany CM, McDannold NJ, Hynynen K, Jolesz FA. Focused ultrasound surgery in oncology: Overview and principles. Radiology 2011;259:39–56
   PubMed Web of Science ®Google Scholar
• Napoli A, Anzidei M, Ciolina F, Marotta E, Cavallo Marincola B, Brachetti G, et al. MR-guided high-intensity focused ultrasound: Current status of an emerging technology. Cardiovasc Intervent Radiol 2013;36:1190–203
   PubMed Web of Science ®Google Scholar
• Hynynen K, Freund WR, Cline HE, Chung AH, Watkins RD, Vetro JP, Jolesz FA. A clinical, noninvasive, MR imaging-monitored ultrasound surgery method. Radiographics 1996;16:185–95
   PubMed Web of Science ®Google Scholar
• De Poorter J, De Wagter C, De Deene Y, Thomsen C, Stahlberg F, Achten E. Noninvasive MRI thermometry with the proton resonance frequency (PRF) method: In vivo results in human muscle. Magn Reson Med 1995;33:74–81
   PubMed Web of Science ®Google Scholar
• Jolesz FA. MRI-guided focused ultrasound surgery. Annu Rev Med 2009;60:417–30
   PubMed Web of Science ®Google Scholar
• Hurwitz MD, Ghanouni P, Kanaev SV, Iozeffi D, Gianfelice D, Fennessy FM, et al. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: Phase III trial results. J Natl Cancer Inst 2014;106. pii: dju082
   PubMedGoogle Scholar
• Catane R, Beck A, Inbar Y, Rabin T, Shabshin N, Hengst S, et al. MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases – Preliminary clinical experience. Ann Oncol 2007;18:163–7
   PubMed Web of Science ®Google Scholar
• Liberman B, Gianfelice D, Inbar Y, Beck A, Rabin T, Shabshin N, et al. Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: A multicenter study. Ann Surg Oncol 2009;16:140–6
   PubMed Web of Science ®Google Scholar
• Gianfelice D, Gupta C, Kucharczyk W, Bret P, Havill D, Clemons M. Palliative treatment of painful bone metastases with MR imaging-guided focused ultrasound. Radiology 2008;249:355–63
   PubMed Web of Science ®Google Scholar
• Napoli A, Anzidei M, Marincola BC, Brachetti G, Ciolina F, Cartocci G, et al. Primary pain palliation and local tumor control in bone metastases treated with magnetic resonance-guided focused ultrasound. Invest Radiol 2013;48:351–8
   PubMed Web of Science ®Google Scholar
• Costelloe CM, Chuang HH, Madewell JE, Ueno NT. Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST. J Cancer 2010;1:80–92
   PubMed Web of Science ®Google Scholar
• Chen L, Ma C, Richardson T, Freedman G, Konski A, Chen, X, et al. TH-E-BRA-03: Clinical experience at Fox Chase Cancer Center for treatment of bone metastases using ExAblate 2000 with MR guidance. Med Phys 2012;39:4012
   Web of Science ®Google Scholar
• Catane R, Gianfelice D, Kawasaki M, Iozeffi D, Kanyev S, Napoli A, et al. Pain palliation of bone metastases using magnetic resonance guided focused ultrasound – Multi-center multi-trial results. Ann Oncol 2012;23:463
   PubMed Web of Science ®Google Scholar
• Turkevich VG, Savelyeva VV, Kanaev SV, Dunaevsky IV, Krzhivitsky PI. Treatment of painful bone metastases with magnetic resonance guided focused ultrasound. Eur J Cancer 2011;47:S227–8
   Web of Science ®Google Scholar
• Salpeter SR, Malter DS, Luo EJ, Lin AY, Stuart B. Systematic review of cancer presentations with a median survival of six months or less. J Palliat Med 2012;15:175–85
   PubMed Web of Science ®Google Scholar
• Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, et al. Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011;79:965–76
   PubMed Web of Science ®Google Scholar
• Chow E, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, et al. Single vs. multiple fractions of repeat radiation for painful bone metastases: A randomised, controlled, non-inferiority trial. Lancet Oncol 2014;15:164–71
   PubMed Web of Science ®Google Scholar
• Candiano G, Russo G, Stefano A, Marino L, Ganguzza F, Vaccari A, et al. Metabolic changes after MRgFUS treatment of a bone metastasis using PET/CT: A case report. Am Inst Phys 12th Int Symp Therapeut Ultrasound 2012;1503:168–72
   Google Scholar
• Kawasaki M, Nanba H, Kato T, Tani T, Ushida T. Efficacy of magnetic resonance-guided focused ultrasound surgery for bone metastases pain palliation. In: Matsumoto Y, Crum LA, TerHaar GR, eds. 10th Int Symp Therapeut Ultrasound, 2011, pp. 488–92
   Google Scholar
• Huisman M, van den Bosch MA, Wijlemans JW, van Vulpen M, van der Linden YM, Verkooijen HM. Effectiveness of re-irradiation for painful bone metastases: A systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 2012;84:8–14
   PubMed Web of Science ®Google Scholar
• Mougenot C, Quesson B, de Senneville BD, de Oliveira PL, Sprinkhuizen S, Palussière J, et al. Three-dimensional spatial and temporal temperature control with MR thermometry-guided focused ultrasound (MRgHIFU). Magn Reson Med 2009;61:603–14
   PubMed Web of Science ®Google Scholar
• de Senneville BD, Mougenot C, Quesson B, Dragonu I, Grenier N, Moonen CT. MR thermometry for monitoring tumor ablation. Eur Radiol 2007;17:2401–10
   PubMed Web of Science ®Google Scholar
• Noorda YH, Bartels LW, Huisman M, Nijenhuis RJ, van den Bosch MA, Pluim JP. Registration of CT to pre-treatment MRI for planning of MR-HIFU ablation treatment of painful bone metastases. Phys Med Biol 2014;59:4167–79
   PubMed Web of Science ®Google Scholar
• Schlesinger D, Benedict S, Diederich C, Gedroyc W, Klibanov A, Larner J. MR-guided focused ultrasound surgery, present and future. Med Phys 2013;40:080901
   PubMed Web of Science ®Google Scholar
• Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer 1987;55:61–6
   PubMed Web of Science ®Google Scholar
• van der Linden YM, Steenland E, van Houwelingen HC, Post WJ, Oei B, Marijnen CA, et al. Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: Results on survival in the Dutch Bone Metastasis Study. Radiother Oncol 2006;78:245–53
   PubMed Web of Science ®Google Scholar
• McMenomy BP, Kurup AN, Johnson GB, Carter RE, McWilliams RR, Markovic SN, et al. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol 2013;24:207–13
   PubMed Web of Science ®Google Scholar
• Ollila DW, Gleisner AL, Hsueh EC. Rationale for complete metastasectomy in patients with stage IV metastatic melanoma. J Surg Oncol 2011;104:420–4
   PubMed Web of Science ®Google Scholar
• Singh D, Yi WS, Brasacchio RA, Muhs AG, Smudzin T, Williams JP, et al. Is there a favorable subset of patients with prostate cancer who develop oligometastases? Int J Radiat Oncol Biol Phys 2004;58:3–10
   PubMed Web of Science ®Google Scholar
• Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol 2011;8:378–82
   PubMed Web of Science ®Google Scholar
• Halabi S, Lin CY, Small EJ, Armstrong AJ, Kaplan EB, Petrylak D, et al. Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy. J Natl Cancer Inst 2013;105:1729–37
   PubMedGoogle Scholar
• Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, et al. Baseline quality of life as a prognostic indicator of survival: A meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 2009;10:865–71
   PubMed Web of Science ®Google Scholar
• Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: A global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999;52:101–9
   PubMed Web of Science ®Google Scholar
• Herman A, Avivi E, Brosh T, Schwartz I, Liberman B. Biomechanical properties of bone treated by magnetic resonance-guided focused ultrasound – An in vivo porcine model study. Bone 2013;57:92–7
   PubMed Web of Science ®Google Scholar
• Smith NB, Temkin JM, Shapiro F, Hynynen K. Thermal effects of focused ultrasound energy on bone tissue. Ultrasound Med Biol 2001;27:1427–33
   PubMed Web of Science ®Google Scholar
• Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: A systematic review. J Clin Oncol 2007;25:1423–36
   PubMed Web of Science ®Google Scholar
• Wattenberg MM, Fahim A, Ahmed MM, Hodge JW. Unlocking the combination: Potentiation of radiation-induced antitumor responses with immunotherapy. Radiat Res 2014;182:126–38
   PubMed Web of Science ®Google Scholar
• Udono H, Srivastava PK. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 1993;178:1391–6
   PubMed Web of Science ®Google Scholar
• Milani V, Noessner E, Ghose S, Kuppner M, Ahrens B, Scharner A, et al. Heat shock protein 70: Role in antigen presentation and immune stimulation. Int J Hyperthermia 2002;18:563–75
   PubMed Web of Science ®Google Scholar
• Hurwitz MD, Kaur P, Nagaraja GM, Bausero MA, Manola J, Asea A. Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. Radiother Oncol 2010;95:350–58
   PubMed Web of Science ®Google Scholar
• van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355(9210):1119–25
   PubMed Web of Science ®Google Scholar
• Staruch R, Chopra R, Hynynen K. Hyperthermia in bone generated with MR imaging-controlled focused ultrasound: Control strategies and drug delivery. Radiology 2012;263:117–27
   PubMed Web of Science ®Google Scholar
• Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med 2013;369:213–23
   PubMed Web of Science ®Google Scholar
• Bradley NM, Chow E, Tsao MN, Danjoux C, Barnes EA, Hayter C, et al. Reasons for poor accrual in palliative radiation therapy research studies. Support Cancer Ther 2006;3:110–19
   PubMedGoogle Scholar
• Lara PN Jr, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, et al. Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728–33
   PubMed Web of Science ®Google Scholar
• Ling J, Rees E, Hardy J. What influences participation in clinical trials in palliative care in a cancer centre? Eur J Cancer 2000;36:621–6
   PubMed Web of Science ®Google Scholar
• Chow E, Hoskin P, Mitera G, Zeng L, Lutz S, Roos D, et al. Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys 2012;82:1730–7
   PubMed Web of Science ®Google Scholar
• Chow E, Wu JS, Hoskin P, Coia LR, Bentzen SM, Blitzer PH. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 2002;64:275–80
   PubMed Web of Science ®Google Scholar
• Orgera G, Monfardini L, Della Vigna P, Zhang L, Bonomo G, Arnone P, et al. High-intensity focused ultrasound (HIFU) in patients with solid malignancies: evaluation of feasibility, local tumour response and clinical results. Radiol Med 2011;116:734–48
   Google Scholar
• Carteret T, Trillaud H, Maire F, et al. MR-guided high intensity focused ultrasound for palliation of bone metastasis. Cardiovascular and interventional radiology 2011;34:539
   Google Scholar
• Orgera G, Bonomo G, Della Vigna P, Monfardini L, Orsi F. US-guided high-intensity focused ultrasound of bone and soft tissues metastases: Early clinical experience in palliation of chronic pain. Cardiovasc Intervent Radiol 2010;33:274–5
   Google Scholar
• Li C, Zhang W, Fan W, Huang J, Zhang F, Wu P. Noninvasive treatment of malignant bone tumors using high-intensity focused ultrasound. Cancer 2010;116:3934–42
   Google Scholar